Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuta Kojima

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Virchows Archiv : an International Journal of Pathology|January 26, 2026
Selective MYC 5' amplification in postirradiation/lymphedema-associated angiosarcomaNaohiro Makise, Ryuta Kojima, Naoki Takeda, et al.
World Journal of Virology|July 3, 2023
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinomaRyuta Kojima, Shingo Nakamoto, Tadayoshi Kogure, et al.
British Journal of Cancer|October 17, 2025
Pan-cancer analysis of RNA expression signatures associated with cancer tissue architectureMegumi Mogi, Katsushige Kawase, Hiroyoshi Y Tanaka, et al.
American Journal of Physiology. Cell Physiology|September 9, 2024
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesisJunjie Ao, Na Qiang, Hiroaki Kanzaki, et al.
Scientific Reports|November 11, 2023
Investigation of risk factors for metachronous recurrence in patients with early gastric adenocarcinoma by miRNA-mRNA integral profilingAriki Nagashima, Kenichiro Okimoto, Ryo Nakagawa, et al.
Oncology Letters|August 13, 2020
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancerYushi Imai, Tetsuhiro Chiba, Takayuki Kondo, et al.
Biochemical Pharmacology|February 27, 2025
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinomaNa Qiang, Junjie Ao, Masato Nakamura, et al.
International Journal of Molecular Sciences|October 14, 2022
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B VirusYaojia Ma, Shingo Nakamoto, Junjie Ao, et al.
Biochemical and Biophysical Research Communications|March 6, 2021
Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cellsJunjie Ao, Tetsuhiro Chiba, Shuhei Shibata, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 2022
A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosisTakafumi Sakuma, Masato Nakamura, Tetsuhiro Chiba, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Virchows Archiv : an International Journal of Pathology|January 26, 2026
Selective MYC 5' amplification in postirradiation/lymphedema-associated angiosarcomaNaohiro Makise, Ryuta Kojima, Naoki Takeda, et al.
World Journal of Virology|July 3, 2023
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinomaRyuta Kojima, Shingo Nakamoto, Tadayoshi Kogure, et al.
British Journal of Cancer|October 17, 2025
Pan-cancer analysis of RNA expression signatures associated with cancer tissue architectureMegumi Mogi, Katsushige Kawase, Hiroyoshi Y Tanaka, et al.
American Journal of Physiology. Cell Physiology|September 9, 2024
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesisJunjie Ao, Na Qiang, Hiroaki Kanzaki, et al.
Scientific Reports|November 11, 2023
Investigation of risk factors for metachronous recurrence in patients with early gastric adenocarcinoma by miRNA-mRNA integral profilingAriki Nagashima, Kenichiro Okimoto, Ryo Nakagawa, et al.
Oncology Letters|August 13, 2020
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancerYushi Imai, Tetsuhiro Chiba, Takayuki Kondo, et al.
Biochemical Pharmacology|February 27, 2025
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinomaNa Qiang, Junjie Ao, Masato Nakamura, et al.
International Journal of Molecular Sciences|October 14, 2022
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B VirusYaojia Ma, Shingo Nakamoto, Junjie Ao, et al.
Biochemical and Biophysical Research Communications|March 6, 2021
Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cellsJunjie Ao, Tetsuhiro Chiba, Shuhei Shibata, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 2022
A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosisTakafumi Sakuma, Masato Nakamura, Tetsuhiro Chiba, et al.
Pageof 2